FDA urges Pharma giants to increase their inclusion of men in new Breast
Cancer trials
The recent FDA recommendations have urged the Pharma companies for the inclusion of men in the clinical trials to test new breast cancer drugs. Men rarely develop Breast cancer. Less than 1% of men develop Breast cancer. And 1 in 1000 Men gets diagnosed with it.
Because of the rarity of the disease in men, they are often excluded or their number is limited in the clinical trials. However, the FDA released new guidelines to urge Healthcare companies to increase the number of males in clinical trials. This is important since the metabolism of men and women vary and the success ...
